StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
27
This year
1
Publishing Date
2024 - 01 - 24
1
2023 - 08 - 24
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 12 - 26
1
2022 - 12 - 09
1
2022 - 08 - 19
1
2022 - 07 - 04
2
2022 - 04 - 26
1
2022 - 04 - 21
1
2021 - 08 - 16
1
2021 - 07 - 23
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 09
1
2021 - 05 - 24
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
1
Sector
Distribution services
1
Health services
1
Health technology
27
Manufacturing
1
N/a
1
Process industries
1
Professional, scientific, and technical services
1
Tags
Antiviral
1
Biotech
1
Breast
1
Cancer
2
Covid-19
1
Disease
1
Drug
2
Financial results
1
Genetic
1
Global
4
Growth
1
Hepatitis
1
Hiv
2
Impact
1
Iot
1
Market
7
N/a
25
News
1
People
1
Pharma
1
Report
4
Research
3
Results
2
Risk
1
Study
3
T-cell
1
Technology
1
Therapeutics
4
Therapy
1
Trials
1
Entities
Abbott laboratories
32
Abbvie inc.
37
Adc therapeutics sa
5
Aerie pharmaceuticals, inc.
5
Agios pharmaceuticals, inc.
10
Alkermes plc
4
Alnylam pharmaceuticals, inc.
14
Amgen inc.
34
Arvinas, inc.
24
Astellas pharma inc
26
Astrazeneca plc
45
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
5
Baxter international inc.
6
Beam therapeutics inc.
6
Becton, dickinson and company
6
Beigene, ltd.
10
Biocryst pharmaceuticals, inc.
14
Biohaven pharmaceutical holding company ltd.
15
Biomarin pharmaceutical inc.
4
Biontech se
95
Blueprint medicines corporation
10
Bristol-myers squibb company
61
Clovis oncology, inc.
11
Eli lilly and company
80
Endo international plc
7
Epizyme, inc.
11
Exelixis, inc.
13
Genmab a/s
4
Gilead sciences, inc.
27
Glaxosmithkline plc
64
Global blood therapeutics, inc.
6
Ideaya biosciences, inc.
4
Illumina, inc.
12
Incyte corporation
14
Ionis pharmaceuticals, inc.
5
Johnson & johnson
76
Karyopharm therapeutics inc.
10
Moderna, inc.
7
Morgan stanley
4
Myovant sciences ltd.
14
Neurocrine biosciences, inc.
4
Novartis ag
88
Novo nordisk a/s
11
Omeros corporation
13
Opko health, inc.
6
Orange
29
Otonomy, inc.
13
Pfizer, inc.
693
Regeneron pharmaceuticals, inc.
22
Rigel pharmaceuticals, inc.
11
Sanofi
153
Seagen inc.
7
Takeda pharmaceutical company limited
23
Teva pharmaceutical industries ltd
29
Verastem, inc.
10
Viatris inc.
8
Voyager therapeutics, inc.
6
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
10
Symbols
AADI
3
ABBV
41
ABT
12
ACLX
7
ADAP
3
ALNY
6
ALPMF
3
ALPMY
3
ALVR
3
AMGN
35
ASMB
6
AZN
10
AZNCF
8
BAX
3
BCRX
13
BIIB
6
BLUE
4
BMRN
4
BMY
45
BNTX
3
CALT
3
CBAY
3
CRSP
3
FNCTF
8
GILD
500
GLAXF
19
GLPG
20
GLPGF
16
GMAB
4
GSK
24
HOOK
16
IMGN
4
JNCE
25
JNJ
43
LLY
35
MGNX
5
MOR
4
MRK
5
NRIX
4
NVO
10
NVS
28
NVSEF
25
OMER
14
OTIC
13
PFE
27
REGN
11
SGMO
4
SNY
64
SNYNF
35
SRNE
4
SRPT
4
TAK
15
TEVJF
10
TMO
4
VERU
4
VIR
6
VRTX
6
VTRS
5
XERS
11
XLO
4
Exchanges
Nasdaq
27
Nyse
27
Crawled Date
2024 - 01 - 24
1
2023 - 08 - 24
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 12 - 26
1
2022 - 12 - 09
1
2022 - 08 - 19
1
2022 - 07 - 04
2
2022 - 04 - 26
1
2022 - 04 - 21
1
2021 - 08 - 16
1
2021 - 07 - 27
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 09
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
2
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
1
Crawled Time
00:00
4
01:00
1
09:00
1
10:00
1
10:51
1
11:00
1
12:15
1
12:34
1
13:00
2
13:07
1
13:17
1
13:20
2
13:27
1
14:00
1
14:03
1
15:00
1
15:49
1
17:00
1
17:43
1
18:32
1
19:47
1
20:00
1
Source
www.biospace.com
2
www.fda.gov
14
www.globenewswire.com
1
www.prnewswire.com
10
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Gilead sciences, inc.
symbols :
Pfe
save search
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-7.63%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-12.03%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.015
-8.85%
140K
|
Health Technology
|
-66.67%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-15.76%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.5
-1.32%
-1.33%
1.7M
|
Health Technology
|
-17.39%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
Everest Medicines Announces Interim Results for First Half of 2023
Published:
2023-08-24
(Crawled : 01:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-28.37%
|
O:
-0.5%
H:
0.45%
C:
-0.86%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-13.1%
|
O:
0.27%
H:
1.15%
C:
-1.19%
CALT
|
$18.0825
-1.71%
1.9K
|
Health Technology
|
1.57%
|
O:
-4.72%
H:
0.0%
C:
0.0%
results
Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.27%
|
O:
-0.2%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-45.12%
|
O:
-2.74%
H:
0.43%
C:
-0.99%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-14.02%
|
O:
0.33%
H:
0.33%
C:
-0.94%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-32.23%
|
O:
0.83%
H:
0.52%
C:
-1.09%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-5.67%
|
O:
-0.01%
H:
0.69%
C:
-0.1%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-6.1%
|
O:
1.1%
H:
0.22%
C:
0.02%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-22.39%
|
O:
-0.26%
H:
0.37%
C:
-0.74%
COCP
|
$1.52
-1.39%
740
|
Health Technology
|
-28.97%
|
O:
0.47%
H:
11.16%
C:
7.91%
hepatitis
global
antiviral
hiv
therapeutics
growth
market
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.69%
|
O:
0.77%
H:
0.0%
C:
-0.74%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
2.68%
|
O:
1.08%
H:
0.0%
C:
-0.25%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-48.84%
|
O:
-0.08%
H:
0.21%
C:
-0.1%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
3.46%
|
O:
-0.01%
H:
0.08%
C:
-0.95%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-16.02%
|
O:
-0.04%
H:
0.16%
C:
-0.47%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-31.84%
|
O:
0.04%
H:
0.21%
C:
-0.25%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.69%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-21.48%
|
O:
0.08%
H:
0.66%
C:
0.61%
EXEL
|
$23.295
1.86%
1.82%
1.9M
|
Health Technology
|
46.04%
|
O:
-0.32%
H:
2.91%
C:
2.75%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
2.98%
|
O:
-0.46%
H:
0.38%
C:
0.01%
global
disease
report
therapeutics
cancer
market
HIV Clinical Trials Market Research Report by Phase, Study Design, Sponsor, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-12-26
(Crawled : 13:20)
- prnewswire.com
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
SYNH
|
$42.98
0.0%
7.4M
|
Health Services
|
Email alert
Add to watchlist
ICLR
|
News
|
$306.16
2.76%
2.68%
860K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
covid-19
trials
research
global
report
hiv
impact
study
market
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model Myriad Genetics, Inc., a leader in genetic testing and preci...
Published:
2022-12-09
(Crawled : 13:00)
- biospace.com/
SXT
|
$69.89
1.33%
0.0%
340K
|
Distribution Services
|
-6.54%
|
O:
-0.42%
H:
0.97%
C:
-0.33%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-49.29%
|
O:
-0.06%
H:
2.11%
C:
-0.06%
TRIB
|
$1.81
-3.87%
2.8K
|
Health Technology
|
41.41%
|
O:
-1.56%
H:
1.58%
C:
-1.75%
REPL
|
$6.41
-0.16%
-0.16%
1.2M
|
Health Technology
|
-73.32%
|
O:
-0.25%
H:
5.25%
C:
4.17%
MYGN
|
$18.595
0.57%
0.56%
510K
|
Health Technology
|
-5.13%
|
O:
-0.67%
H:
1.39%
C:
-2.69%
IMGN
|
News
|
$31.23
0.03%
49M
|
Health Technology
|
501.93%
|
O:
-0.19%
H:
0.77%
C:
-0.77%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-25.17%
|
O:
-0.23%
H:
0.0%
C:
-1.45%
BNTX
|
News
|
$88.53
0.59%
0.59%
360K
|
Health Technology
|
-48.77%
|
O:
-0.05%
H:
0.75%
C:
-0.83%
APM
|
$5.37
-5.12%
-5.6%
35K
|
Health Technology
|
10.98%
|
O:
-16.14%
H:
19.24%
C:
14.67%
risk
breast
genetic
cancer
study
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published:
2022-08-19
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
6.58%
|
O:
3.04%
H:
0.12%
C:
-2.22%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-5.78%
|
O:
-2.05%
H:
0.29%
C:
0.07%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-45.94%
|
O:
0.54%
H:
1.24%
C:
0.63%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-33.73%
|
O:
0.01%
H:
2.09%
C:
1.58%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
44.06%
|
O:
-0.62%
H:
0.57%
C:
-0.42%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
2.72%
|
O:
-0.25%
H:
1.19%
C:
0.49%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.46%
|
O:
0.78%
H:
0.49%
C:
0.22%
study
market
A $41.8 Billion Global Opportunity for Small Molecule Drug Discovery by 2026 - New Research from StrategyR
Published:
2022-07-04
(Crawled : 11:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
drug
research
With Market Size Valued at $13.7 Billion by 2026, it`s a Healthy Outlook for the Global Angina Pectoris Drugs Market
Published:
2022-07-04
(Crawled : 09:00)
- prnewswire.com
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
market
Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published:
2022-04-26
(Crawled : 13:20)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.47%
|
O:
-1.81%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.27%
|
O:
3.09%
H:
0.0%
C:
-2.9%
UCBJY
|
$64.93
-4.38%
6.2K
|
Manufacturing
|
11.12%
|
O:
-0.33%
H:
0.0%
C:
-1.56%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
1.04%
|
O:
-1.19%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-8.3%
|
O:
-0.48%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-45.08%
|
O:
3.08%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-18.34%
|
O:
2.0%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
156.43%
|
O:
0.34%
H:
1.41%
C:
-1.17%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-35.38%
|
O:
-0.09%
H:
1.26%
C:
-0.51%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
46.34%
|
O:
-0.22%
H:
0.43%
C:
-1.25%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-14.37%
|
O:
-0.11%
H:
0.0%
C:
0.0%
RIGL
|
$1.135
0.44%
0.44%
520K
|
Health Technology
|
-57.36%
|
O:
-0.38%
H:
4.92%
C:
-4.55%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
30.4%
|
O:
-0.72%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
6.86%
|
O:
-0.13%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
6.32%
|
O:
-0.03%
H:
0.53%
C:
-1.33%
research
report
therapeutics
market
FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board
Published:
2022-04-21
(Crawled : 13:00)
- biospace.com/
SYK
|
$334.91
2.21%
-4.72%
1.4M
|
Health Technology
|
20.01%
|
O:
1.27%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-47.48%
|
O:
-0.16%
H:
0.0%
C:
0.0%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-35.38%
|
O:
1.59%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
6.14%
|
O:
0.68%
H:
0.0%
C:
0.0%
HUGE
|
News
|
$0.469
-4.09%
-4.26%
110K
|
Process Industries
|
-53.72%
|
O:
0.0%
H:
0.0%
C:
0.0%
pharma
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
Published:
2021-08-16
(Crawled : 12:15)
- globenewswire.com
AVTE
M
|
$23.235
4.8%
4.58%
150K
|
Professional, Scientific, and T...
|
67.32%
|
O:
-8.86%
H:
4.83%
C:
3.51%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-44.72%
|
O:
1.54%
H:
1.53%
C:
1.41%
VYGR
|
News
|
$7.645
0.99%
0.98%
370K
|
Health Technology
|
150.66%
|
O:
-3.31%
H:
2.05%
C:
-1.37%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-5.53%
|
O:
0.56%
H:
0.81%
C:
0.62%
financial results
results
therapeutics
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-07-23
(Crawled : 00:00)
- fda.gov
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
Email alert
Add to watchlist
SCYX
|
$1.53
6.25%
5.88%
150K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-24
(Crawled : 14:03)
- fda.gov
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-32.75%
|
O:
0.23%
H:
0.52%
C:
0.13%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
236.86%
|
O:
8.21%
H:
1.89%
C:
-0.83%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-24.7%
|
O:
0.31%
H:
1.15%
C:
0.6%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
47.27%
|
O:
0.37%
H:
1.55%
C:
0.28%
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
-54.36%
|
O:
0.0%
H:
10.77%
C:
10.77%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-11.15%
|
O:
0.29%
H:
0.8%
C:
0.17%
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
-80.06%
|
O:
0.32%
H:
0.87%
C:
0.26%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
0.45%
|
O:
0.18%
H:
2.2%
C:
0.61%
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
-74.04%
|
O:
0.06%
H:
0.35%
C:
0.0%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
13.91%
|
O:
0.71%
H:
1.09%
C:
0.22%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-32.34%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
234.63%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-26.07%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
48.42%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
-56.69%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-12.46%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
-79.55%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
0.51%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
-72.25%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
13.92%
|
O:
0.4%
H:
0.53%
C:
0.25%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-09
(Crawled : 10:51)
- fda.gov
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-32.41%
|
O:
0.39%
H:
2.15%
C:
2.08%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
231.37%
|
O:
0.29%
H:
2.43%
C:
2.1%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-22.86%
|
O:
0.5%
H:
2.39%
C:
2.16%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
49.45%
|
O:
0.48%
H:
1.36%
C:
0.99%
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
-54.36%
|
O:
7.18%
H:
4.52%
C:
-4.07%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-11.11%
|
O:
0.88%
H:
0.74%
C:
0.5%
OTIC
|
$0.077
|
Health Technology
|
-96.75%
|
O:
-0.84%
H:
5.93%
C:
0.42%
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
-80.57%
|
O:
0.95%
H:
2.0%
C:
0.25%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-0.83%
|
O:
0.09%
H:
2.4%
C:
1.6%
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
-74.12%
|
O:
0.82%
H:
2.39%
C:
-1.11%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
14.82%
|
O:
0.46%
H:
1.42%
C:
0.67%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-24
(Crawled : 00:00)
- fda.gov
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-34.27%
|
O:
0.33%
H:
0.15%
C:
-0.67%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
265.88%
|
O:
0.56%
H:
1.3%
C:
0.01%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-26.71%
|
O:
0.33%
H:
1.03%
C:
0.03%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
44.58%
|
O:
0.4%
H:
0.19%
C:
-0.58%
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
-48.7%
|
O:
-1.15%
H:
1.46%
C:
-4.66%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-14.02%
|
O:
0.02%
H:
0.3%
C:
-0.3%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
77.64%
|
O:
0.6%
H:
0.0%
C:
-1.82%
OTIC
|
$0.077
|
Health Technology
|
-96.87%
|
O:
1.21%
H:
0.0%
C:
-7.2%
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
-79.31%
|
O:
0.94%
H:
1.4%
C:
1.06%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-2.62%
|
O:
0.51%
H:
0.2%
C:
-2.42%
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
-68.18%
|
O:
0.43%
H:
1.44%
C:
-2.16%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
8.33%
|
O:
-0.18%
H:
1.17%
C:
-1.12%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-18
(Crawled : 13:27)
- fda.gov
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-34.53%
|
O:
0.17%
H:
0.41%
C:
-0.32%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
274.02%
|
O:
-0.27%
H:
0.69%
C:
-0.19%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-24.93%
|
O:
-0.06%
H:
0.58%
C:
0.28%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
43.63%
|
O:
-0.67%
H:
1.54%
C:
0.95%
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
-48.85%
|
O:
0.0%
H:
5.46%
C:
3.16%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-13.49%
|
O:
0.22%
H:
0.1%
C:
-0.26%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
71.87%
|
O:
-0.14%
H:
0.0%
C:
-1.3%
OTIC
|
$0.077
|
Health Technology
|
-96.73%
|
O:
-0.84%
H:
4.63%
C:
1.7%
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
-82.69%
|
O:
0.06%
H:
1.35%
C:
-0.06%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-3.07%
|
O:
0.49%
H:
0.66%
C:
-0.81%
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
-69.33%
|
O:
-0.76%
H:
4.91%
C:
0.77%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
7.74%
|
O:
-0.12%
H:
0.4%
C:
-0.48%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-12
(Crawled : 17:43)
- fda.gov
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-33.27%
|
O:
0.23%
H:
1.22%
C:
0.63%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
275.52%
|
O:
0.0%
H:
0.46%
C:
-0.8%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-23.53%
|
O:
0.26%
H:
1.24%
C:
0.16%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
46.13%
|
O:
-0.03%
H:
1.0%
C:
0.1%
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
-47.95%
|
O:
-2.68%
H:
7.56%
C:
0.05%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-10.92%
|
O:
-0.46%
H:
0.95%
C:
0.12%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
79.6%
|
O:
-0.84%
H:
3.35%
C:
2.04%
OTIC
|
$0.077
|
Health Technology
|
-96.28%
|
O:
1.92%
H:
4.25%
C:
1.42%
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
-83.29%
|
O:
-1.41%
H:
2.86%
C:
-1.76%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-0.4%
|
O:
-0.7%
H:
1.8%
C:
1.05%
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
-63.67%
|
O:
-1.98%
H:
6.47%
C:
4.96%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
7.77%
|
O:
-0.35%
H:
0.92%
C:
-0.23%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-22
(Crawled : 12:34)
- fda.gov
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-33.57%
|
O:
-0.13%
H:
0.05%
C:
-2.13%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
283.0%
|
O:
-0.5%
H:
0.67%
C:
-1.55%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-25.9%
|
O:
-0.26%
H:
0.62%
C:
0.26%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
51.53%
|
O:
-0.14%
H:
0.4%
C:
-0.54%
XERS
|
$1.78
0.0%
1.3M
|
Health Technology
|
-54.12%
|
O:
0.26%
H:
4.37%
C:
-0.26%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-11.79%
|
O:
-0.93%
H:
0.27%
C:
0.17%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
77.73%
|
O:
-0.21%
H:
0.0%
C:
-2.96%
OTIC
|
$0.077
|
Health Technology
|
-96.61%
|
O:
0.0%
H:
3.51%
C:
0.88%
OMER
|
$3.08
0.0%
210K
|
Health Technology
|
-83.9%
|
O:
0.1%
H:
0.31%
C:
-3.03%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
0.24%
|
O:
-0.46%
H:
0.05%
C:
-1.26%
BCRX
|
News
|
$4.375
-0.79%
-0.8%
4.2M
|
Health Technology
|
-62.18%
|
O:
-0.34%
H:
8.09%
C:
3.7%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
5.07%
|
O:
-0.48%
H:
0.36%
C:
-0.97%
← Previous
1
2
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.